Add Yahoo as a preferred source to see more of our stories on Google. Neisseria gonorrhoeae is the type of bacteria that causes gonorrhea, a sexually transmitted infection. - Center for Disease ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a new study published Monday in The Lancet. The drug, called gepotidacin, ...

The Massachusetts Department of Public Health announced on Thursday two cases of a novel strain of gonorrhea—one which is resistant to five classes of antibiotic treatment, and which health officials ...

Notorious infection monitors the environment and waits for its opportunity You know that package warning that oral birth control won’t prevent STIs? Well in the case of gonorrhea, the sexually ...

A new treatment for gonorrhea shows promise, which is welcome news with global rates of the sexually transmitted infection on the rise and antibiotic resistance becoming more prevalent. The oral ...

Please provide your email address to receive an email when new articles are posted on . A trial that evaluated three alternative treatments for anogenital gonorrhea found that a single dose of ...

Please provide your email address to receive an email when new articles are posted on . Gonorrhea has become increasingly resistant to existing antibiotics. Two newly approved drugs, gepotidacin and ...

Gonorrhea is a common sexually transmitted disease (STD) that causes infection in more than 1.5 million people every year in the United States. The infection is caused by Neisseria gonorrhoeae, a type ...

An existing vaccine that prevents meningococcal disease may also be up to 40 percent effective at preventing gonorrhea infections, which are becoming increasingly resistant to antibiotics, with some ...

(CNN) — A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a new study finds. This could put the medication, called gepotidacin, ...

The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday. "The ability of N.